Select a day below to view the schedule. Sessions are colour-coded by scientific track.
Tuesday, 24 November 2026 · YCIP Programme & Endoscopy Hands-on Workshops
| TIME | JGHF-APDWF Young Clinical Investigator Program (YCIP) | Endoscopy Hands-on Workshops | ||
|---|---|---|---|---|
| 0900 – 1030 |
YCIP Session 1
|
Upper GI Therapeutic Endoscopy Hands-on Workshop
|
Lower GI Therapeutic Endoscopy Hands-on Workshop
|
Basic ERCP Hands-on Workshop
|
| 1030 – 1100 | Tea Break | |||
| 1100 – 1230 |
YCIP Session 2
|
|||
| 1230 – 1400 |
Lunch Symposium
|
|||
| 1400 – 1530 |
YCIP Session 3
|
Lower GI Therapeutic Endoscopy Hands-on Workshop
|
Upper GI Therapeutic Endoscopy Hands-on Workshop
|
Advanced ERCP Hand-on Workshop
|
| 1530 – 1600 | Tea Break | |||
| 1600 – 1730 |
YCIP Session 3
|
|||
o Wednesday, 25 November 2026 – Postgraduate Course, Women in GI, EUS Masterclass, A-PSDE partnered Workshops & IUS Workshop
| TIME | Postgraduate Course | Women in GI Symposium | A-PSDE Partnered Workshops | Intestinal Ultrasound Workshop’ |
|---|---|---|---|---|
| 0900 – 1030 |
Gastroenterology Session
Decoding GERD Phenotypes from Symptoms to Management
Current Recommendations for H. pylori Screening, Testing and Eradication therapy IBD: What is New and Noteworthy Updates in Acute Pancreatitis Treatment: What Clinicians Need to Know |
Women in GI
Symposium 1 |
A-PSDE-WEO Outreach Session
|
IUS Session 1
Hands-on Session 1
|
| 1030 – 1100 | Tea Break | |||
| 1100 – 1230 |
Hepatology Session
MAFLD: Risk Stratification Tools and Cost-effective
Algorithms
Imaging in Liver Tumors: When and How to Use your Diagnostic Tools Managing Compensated Cirrhosis in Outpatient Settings Expanding Treatment Eligibility in Hepatitis B: Lessons from Recent Guidelines |
Women in GI
Symposium 2 |
A-PSDE-WEO CRC SC
|
IUS Session 2
Hands-on Session 2
|
| 1230 – 1400 |
Lunch Symposium
|
|||
| 1400 – 1530 |
Surgical Symposium
Gallstones Without Symptoms: To Cut or Not to Cut
Surgical Options for Obesity Pre-operative Evaluation of a Cirrhotic Patient Optimizing Perioperative Nutrition |
EUS Masterclass
|
A-PSDE – ANBIIG Symposium
|
IUS Session 3
Hands-on Session 3
|
| 1530 – 1600 | Tea Break | |||
| 1600 – 1730 |
Endoscopy Symposium
Improving Metrics in Quality Colonoscopy
Image-Enhanced Endoscopy: Colon Lesions Resection Techniques and Tips in Epithelial Lesions Lower GI Bleeding: From Presentation to Intervention |
EUS Masterclass
|
IUS Session 4
Hands-on Session 4
|
|
Thursday, 26 November 2026 – Opening Ceremony, Plenary Lectures, State-of-the-Art Lectures, Symposia & Free Papers
| TIME | ROOM 1 | ROOM 2 | ROOM 3 | ROOM 4 | ROOM 5 |
|---|---|---|---|---|---|
| 0800 – 0910 |
Symposium 1
IBD in Special Situations
Pediatrics: Problems in the Young
Elderly: Challenges in the Aging Population Pregnancy: Optimizing Maternal and Fetal Outcomes |
Symposium 2
Image Enhanced Endoscopy
Image Enhancement Technologies: Current and Future
Applications
Chromoendoscopy in the Era of IEE IEE in the Era of AI |
Symposium 3
Viral Hepatitis
Hepatitis C Elimination: Are We on Track?
Hepatitis C in the Post-DAA Era: Remaining Challenges Delta Hepatitis: Current Therapeutic Options |
Symposium 4
GI Malignancy
Esophageal Carcinoma: Improving Outcomes
Rectal Carcinoma: Ensuring Total Mesorectal Excision Pancreatic Adenocarcinoma: Pushing the Limit Improves Survival? |
Free Paper |
| 0910 – 1100 |
Opening Ceremony & Plenary Lectures
JGHF – APDWF Okuda State of the Art Lectureship
KL Goh Memorial Lecture Opening Ceremony Presidential Lecture |
||||
| 1100 – 1130 | Tea Break | ||||
| 1130 – 1200 |
State-of-the-Art 1
Challenges in DGBI Overlap: Best Evidence in Management
|
State-of-the-Art 2
Simulation Training in Endoscopy Works
|
State-of-the-Art 3
Hepatitis B Functional Cure: From Concept to Clinical Reality
|
State-of-the-Art 4
Pancreatic Carcinoma: Current and Future directions
|
|
| 1200 – 1330 |
Industry Lunch Symposium 1
|
Industry Lunch Symposium 2
|
Industry Lunch Symposium 3
|
Industry Lunch Symposium 4
|
|
|
1330 – 1440 (70min) |
Symposium 5
Refractory GERD
Medical Strategies Beyond Acid Suppression
From Scope to Solution: Endoscopic Approaches Cutting Through the Reflux: Surgical Strategies |
Symposium 6
Luminal Endoscopy
Underwater EMR/ESD: Advantages and Problems
Managing Complications in Luminal Resection Endoscopic Full Thickness Resection: Indications and Challenges |
Symposium 7
Chronic Diarrhea
HIV-associated: Diagnostic Challenges and Management
Strategies
Microscopic Colitis: Approach to Diagnosis and Management IBS-D and Microbiome: Is Dysbiosis the Core of the Problem? |
Symposium 8
Autoimmune Liver Disease
Novel Therapies in Primary Biliary Cholangitis
The Great Mimic: Differentiating Autoimmune Hepatitis From its Lookalikes IgG-4 Related Disease: Recognition and Management |
Free Paper
|
| 1440 - 1510 | Tea Break | ||||
| 1510 – 1620 |
Symposium 9
IBD Treatment
Optimizing Conventional Before Reaching for Advanced Therapy
Dual Targeted Therapy: The Perfect Combination Anti-fibrotics: A Hope for Stricturing Crohn's? |
Symposium 10
Esophageal Disorders
Recognition to Stepwise Therapy for EoE
EGJOO: Essential Insights for Clinicians Tailored Approaches to Benign Esophageal Stricture Therapy |
Symposium 11
Redefining Endoscopy
Sustainability in GI endoscopy in Asia
Single-use Endoscopes and Tools: Reducing Infection, Improving Workflow Applying Ergonomics in the Endoscopy Room |
Symposium 12
Acute Liver Disorders
Holding the Line for Acute Liver Failure Patients Before
Transplant
Managing Immunotherapy Related Hepatotoxicity Vascular Emergencies in Hepatology: Recognition and Management |
Free Paper
|
Friday, 27 November 2026 – Named Lectureships, Live Endoscopy, State-of-the-Art Lecture, Symposia & Free Papers
| TIME | ROOM 1 | ROOM 2 | ROOM 3 | ROOM 4 | ROOM 5 |
|---|---|---|---|---|---|
| 0800 – 0850 |
Symposium 13
Acute Pancreatitis
Optimizing Treatment in the Early Phase
Management of Extrapancreatic Complications |
Symposium 14
Luminal Stenting
Luminal Stents vs. EUS-guided Gastroenterostomy for GOO
Troubleshooting Malfunctioning Luminal Stents |
Symposium 15
Eosinophilic Diseases
Eosinophilic Enteritis: Recognition and Approach to Therapy
Food Allergy in Asia: Diagnostic Difficulties |
Symposium 16
GERD and Hiatal Hernia
Essential Prerequisites for Effective Hernia Management
Endoscopic Treatment and Outcomes |
Free Paper
|
|
0900 – 0930 (30min) |
JGHF–APDWF Marshall & Warren Lectureship
|
||||
|
0930 – 1000 (30min) |
JGHF–APDWF Emerging Leader Lectureship 1
|
Live Endoscopy Demonstration Session
|
JGHF–APDWF Emerging Leader Lectureship 2
|
JGHF- APDWF Emerging leader Lectureship on Allied Health and
Nursing
|
Free Paper
|
| 1000 – 1030 | Tea Break | ||||
| 1030 – 1100 |
APAGE-WGO Distinguished Lectureship
|
Live Endoscopy Demonstration Session
|
State-of-the-Art
Lecture 5
APAGE Green and Sustainability Initiative - From Vision to
Implementation
|
Debate 1: IBD Management Strategy
Top-down biologic treatment is Still Superior or Not
|
|
|
1100 – 1230 (90 Min) |
Symposium 17
Liver Cancer Treatment
HCC Staging and Treatment in the Asia-Pacific: Bridging Global
Algorithms with Local Realities
Locoregional Therapies: When, How and for Whom? Combination Systemic and Locoregional Treatment in Intermediate to Advanced HCC Advances in Systemic Therapies for Intrahepatic Cholangiocarcinoma |
Symposium 18
Gastric Cancer
Enhancing Early Detection: Biomarkers and Endoscopy
Evolving Management Paradigms Towards Improved Survival Primary Chemoprevention Extended Lymphadenectomy: Balancing Radicality and Safety |
APAGE-AGA Joint Symposium
|
Free Paper
|
|
|
1230 – 1400 (90 Min) |
Industry Lunch Symposium 5
|
Industry Lunch Symposium 6
|
Industry Lunch Symposium 7
|
Industry Lunch Symposium 8
|
|
| 1400 – 1510 |
Symposium 19
Alcohol Associated Liver Diseases
Unveiling the Burden of Alcohol Use Disorder and Shaping Public
Health Policy in the Asia-Pacific
Early Detection and Medical Management of Alcoholic hepatitis Liver Transplantation for Alcohol Related Disease: Candidate Selection and Post-transplant care |
Live Endoscopy Demonstration Session
|
Symposium 20
Irritable Bowel Syndrome
Role of Post Infectious Inflammation and Immune Activation
Management Implications of GUT Brain Axis Dysbiosis: Best Evidence for Probiotics, Antibiotics |
Symposium 21
Obesity
Dealing with Obesity Through Pharmacotherapy
Endoscopic Therapy for Obesity Bariatric Surgery: Is it Worth the Risk? |
Free Paper
|
| 1510 – 1620 |
Symposium 22
Inflammatory Bowel Diseases
Hidden Plastics, Hidden Inflammation: Microplastics
Dietary Interventions and Nutritional Considerations Beyond the GUT: Mental Health and Chronic Fatigue |
Symposium 23
HCC Screening
Optimizing HCC Screening: Integrating Risk Models, Advanced
Imaging and Novel Biomarkers
Liquid Biopsy for Early Detection, Prognostication and Risk Stratification Risk Assessment for HCC Development in Non-cirrhotic MAFLD |
Symposium 24
GI Bleeding
Diagnostic Strategies in Obscure and Overt Presentations
Risk and Prevention of Bleeding with DOACs Rescue in Endoscopic Intervention Failure |
Free Paper
|
|
| 1620 – 1730 | |||||
Saturday, 28 November 2026 · Meet-the-Expert, State-of-the-Art Lectures, Closing Ceremony & Final Symposia
| TIME | ROOM 1 | ROOM 2 | ROOM 3 | ROOM 4 |
|---|---|---|---|---|
|
0800 – 1910 (70min) |
Symposium 25
Functional Dyspepsia
Implications of Disordered Microbiome and Duodenocentric
Inflammations
Symptom Based Management: Promises, Pitfalls and Practicality Biomarkers and Novel Therapies |
Symposium 26
Emerging Endoscopy
Endoscopic Resection of Upper GI Subepithelial Lesions
Third Space Endoscopy Endoscopic Closure Techniques |
Symposium 27
Portal Hypertension
Non-invasive Assessment of Portal Hypertension
Managing Hyponatremia in Cirrhotic Patients with Ascites Renal Replacement Therapy in Hepatorenal Syndrome: Use and Misuse |
Symposium 28
Intestinal Diseases
Rectal Subepithelial Lesion: Different Resection Strategies
Coeliac Disease: Establishing Diagnosis and Pitfalls Overlap Between IBS and Non-celiac Gluten Sensitivity |
|
0910 – 1020 (70min) |
Symposium 29
Novel IBD Treatments
P19 Subunit of IL23: Promises Delivered?
Targeting the JAK-STAT Pathway: From Bench to Bedside Nano Drug Delivery System and Stem Cells Therapy |
Symposium 30
Endohepatology
Beyond HVPG: EUS-guided Portal Pressure Gradient as a New
Standard
EUS-guided Liver Biopsy: Redefining Tissue Acquisition in Hepatology Practice From Banding to Coil: EUS-guided Therapy for Portal Hypertension and Varices |
Symposium 31
Liver Transplant
Management of Post-transplant Surgical Complications
How Far Should We Go? HCC Downstaging and Expanded Transplant Criteria Extended Criteria Donors and Machine Perfusion Strategies in Liver Transplantation |
Symposium 32
Autoimmune Pancreatitis
Issues in Diagnosis and Management
Differentiating Type 1 and 2: Basis and Importance Managing Extrapancreatic Manifestations |
| 1020 – 1050 | Tea Break | |||
| 1050 – 120 |
Symposium 33
New APASL Guidelines: Highlights
Drug Induced Liver Injury
Herbal Induced Liver Injury Chronic Hepatitis B |
Symposium 34
Distal Cholangiocarcinoma
Improving Diagnostic Yield and Avoiding Pitfalls
Optimal Endoscopic Management Surgical Challenges |
Symposium 35
Pancreaticobiliary Endoscopy
Management of Difficult Choledocholithiasis
Balloon-assisted ERCP in Surgically Altered Anatomy Current Options and Approach for Indeterminate Strictures |
Young Investigator Awards
|
| 1200 – 1330 |
Industry Lunch Symposium 9
|
Industry Lunch Symposium 10
|
Industry Lunch Symposium 11
|
|
|
1330 – 1400 (30mins) |
Closing Ceremony
Young Investigator Awards (Oral Abstracts) · Posters of
Distinction Awards · Handover Ceremony
|
|||
| 1400 – 143 |
State-of-the-Art
Lecture 6
CRC Screening in Asia: Achieving Adherence
|
State-of-the-Art
Lecture 7
Positioning of IBD Treatments for 2026
|
State-of-the-Art
Lecture 8
The Promise of Fecal Microbiota Transplantation in
Gastroenterology: Fact or Faux
|
State-of-the-Art
Lecture 9
Comprehensive Management of MAFLD in 2026: From Risk
Identification to Long-term Outcomes in Asia-Pacific
|
| 1430 – 154 |
Debate 2: Endoscopic Resection Technique
Managing Colorectal Flat Lesions (EMR vs ESD)
|
Symposium 36
Chronic Pancreatitis
Idiopathic Chronic Pancreatitis: Is this Still Possible in
2026
Hereditary Pancreatitis: What a Gastroenterologist Needs to Know Improving Early Diagnosis and Management |
Symposium 37
ACLF
Acute on Chronic Liver Failure: Is Consensus Achievable in
2026
Prognostic Biomarkers for ACLF Outcomes Management Strategies for ACLF-related Infections and Sepsis |
Symposium 38
Endoscopic Ultrasonography
EUS in Difficult ERCP
Role of EUS in Chronic Pancreatitis EUS for Pancreatic Neoplasms: Palliation and Cure |
|
Debate 3: Anticoagulation for Bland PVT
In Patients with Cirrhosis and Bland PVT, Anticoagulation Should
be Routinely Used: Pros and Cons
|
||||
| 1540 – 165 |
Symposium 39
MAFLD
Pediatric MAFLD: The Growing Burden in Young Livers
Impact of Moderate Alcohol Consumption on Fibrosis in MAFLD Emerging Pharmacotherapies Targeting Metabolic Pathways in MAFLD |
Symposium 40
Smart and Sustainable Hepatology
Green Perspectives on Chronic Liver Disease Management
AI-driven Innovations in Non-invasive Staging and Diagnosis of Hepatobiliary Disorders Artificial Intelligence in Hepatology: From Prognostic Modelling to Guided Treatment Decisions |
Symposium 41
IBD Response Monitoring
IUS in Predicting Early Response, Complications, Adherence and
Compliance
Wearables and Remote Monitoring Endoscopic Technologies in Disease Control, Predicting Loss of Response, Complications |
Symposium 42
Systemic Therapy in HCC
First-line Systemic Therapy: TKI's, Immunotherapy and
Combination Regimens
Optimal Systemic Therapy Sequencing: How I do it? Future Horizons in HCC: Emerging Systemic Therapies and Precision Strategies |
| 1650 |
END OF CONGRESS
|
|||
This programme is provisional and subject to change without prior notice. Please refer to this official APDW 2026 website for the most up-to-date programme information.
Learn
Contact
General Enquiries
Venue
Philippine International Convention Center
CCP Complex, Roxas Blvd, Manila
Congress Dates
24–28 November 2026
© 2026 APDW 2026 Manila Organising Committee. All rights reserved.
